Based on these findings, we hypothesize that the ectopic expression of TRPM1 in tumor cells of some CAR and MAR patients may result in aberrant production of autoantibodies to TRPM1 through B-lymphocytic responses [29]–[32]. The gene discussed is TRPM1; the disease is neoplasm.